|
Volumn 35, Issue 5, 2005, Pages 521-522
|
CD34+ selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure (multiple letters) [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSULFAN;
CD34 ANTIGEN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
CYTARABINE;
DAUNORUBICIN;
ERYTHROPOIETIN;
ETOPOSIDE;
FOSCARNET SODIUM;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ANEMIA;
APHERESIS;
BONE MARROW BIOPSY;
CASE REPORT;
CYTOMEGALOVIRUS INFECTION;
FEMALE;
GRAFT FAILURE;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL;
HEMORRHAGIC CYSTITIS;
HLA MATCHING;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
NEUTROPENIA;
PRIORITY JOURNAL;
T LYMPHOCYTE;
THROMBOCYTOPENIA;
ADULT;
ANTIGENS, CD34;
FEMALE;
GRAFT REJECTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOID;
SALVAGE THERAPY;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 20144373993
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1704805 Document Type: Letter |
Times cited : (9)
|
References (0)
|